Showing results (1-10 of 273) with videos related to
Sort By:
Pageof 28
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1987
Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivoR J Sheldon, L Nunan, F PorrecaThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivoR J Sheldon, L Nunan, F PorrecaEuropean Journal of Pharmacology|February 9, 1988
U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sitesR J Sheldon, L Nunan, F PorrecaThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1990
Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sitesQ Jiang, R J Sheldon, F PorrecaLife Sciences|November 30, 1987
A comparison of the central gastrointestinal antitransit effects of morphine and bombesin in the mouseQ Jiang, R J Sheldon, F PorrecaGastroenterology|November 1, 1988
Sites of clonidine action to inhibit gut propulsion in mice: demonstration of a central componentQ Jiang, R J Sheldon, F PorrecaPeptides|July 1, 1987
Effects of a novel opioid peptide antagonist on rat bladder motility in vivoF Porreca, L Nunan, W Kazmierski, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Effects of nerve stimulation on ion transport in mouse jejunum: responses to Veratrum alkaloidsR J Sheldon, M E Malarchik, T F Burks, et al.Regulatory Peptides|April 24, 1990
Gastrointestinal motor effects of corticotropin-releasing factor in miceR J Sheldon, J A Qi, F Porreca, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in miceJ A Qi, J S Heyman, R J Sheldon, et al.Pageof 28